Gene signatures derived from transcriptomic data using machine Background: learning methods have shown promise for biodosimetry testing. These signatures may not be sufficiently robust for large scale testing, as their performance has not been adequately validated on external, independent datasets. The present study develops human and murine signatures with biochemically-inspired machine learning that are strictly validated using k-fold and traditional approaches.
Introduction
Potential radiation exposures from industrial nuclear accidents, military incidents, or terrorism are threats to public health 1 . There is a need for large scale biodosimetry testing, which requires efficient screening techniques to differentiate exposed individuals from non-exposed individuals and to determine the severity of exposure 2 . Current diagnostic techniques, including the cytogenetic gold standard [3] [4] [5] [6] , may require several days to provide accurate dose estimates 1, 7 of large cohorts. To address the need for faster diagnostic techniques that accurately measure radiation exposures, gene signatures based on transcriptomic data have been introduced [7] [8] [9] [10] . Probit regression models of radiation response using 25 probes on peripheral blood samples achieved up to 90% accuracy for distinguishing between irradiated blood samples and unirradiated controls 9 . A 74-gene classifier based on nearest centroid expression levels was 98% accurate in distinguishing four levels of irradiation from controls 10 . This level of performance implies that samples exposed to different levels of radiation may be distinguishable based on mRNA expression levels of different genes. While this suggests the feasibility of transcriptional modeling of radiation responses, validation with external datasets is required to establish its reliability for rapid diagnostics. A caveat of these signatures is that they have not all been externally validated on datasets independent of the source data used for model development. A 29-gene signature modelled using a support vector machine (SVM) was externally validated on such a dataset, resulting in 80% accuracy in distinguishing higher (≥8Gy) from lower dose (≤2Gy) radiation exposure in novel samples 7 . The present study derives signatures with improved performance on externally validated samples by employing a different selection of modelling techniques. The machine learning pipeline used here addresses some of the previous limitations through a more rigorous feature selection process and stricter validation procedures.
Previously, the Student's t-test 7 , the F-test 10 , and correlation coefficients 9 were used to identify potential radiation biomarker genes. Although statistical criteria can distinguish genes that are differentially expressed upon radiation exposure, they do not eliminate expressed genes with redundant responses to radiation exposure. Redundancy increases the possibility of overfitting, thereby reducing the generalizability of these models to predict responses in independent datasets. We address this limitation with the information theory-based criterion for gene selection known as minimum redundancy maximum relevance (mRMR) [11] [12] [13] , which ranks genes according to shared mutual information between expression levels and radiation dose (relevance), and by minimizing mutual information shared by expression values of these and other genes (redundancy) 11, 12 . mRMR outperforms ranking criteria based solely on maximizing relevance 12 . In contrast with heuristic approaches like differential expression, we only consider genes with evidence of a relationship to radiation response, which significantly limits the number of model features. Biochemicallyinspired genomic machine learning (ML) has been used to derive high performing gene signatures that predict chemotherapy and hormone therapy responses [13] [14] [15] . From an initial set of mRMRderived biochemically relevant genes, wrapper approaches for feature selection 16 are used to find an optimal set of genes that predict exposure to radiation.
It can be challenging to obtain highly accurate models that perform well on externally validated samples for several reasons. Aside from biases in training data, batch effects and lack of reproducibility may introduce systematic and random sources of variability into gene expression microarray data. Different source datasets can impact data normalization, reducing model performance. We utilize two validation procedures. The first is a signature-centric approach that mirrors external k-fold validation 7 . The limitation of signature-centric validation is that, while signatures allow for the identification of important genes associated with radiation response, a tangible model is required to generate actual diagnostic predictions. To address this limitation, we also use a second model-centric approach, which we term "traditional validation". This procedure applies quantile normalization to training and test data before a model is fitted to the training data. This quantile method has been shown to be more effective than scaling, loess, contrast, and non-linear methods in reducing variation between microarray data 17 . Model validation was not expected to perform as well as signature validation, because quantile normalization is not always successful in eliminating variation between microarray datasets, whereas k-fold validation is independent of this source of variation. This study shows that robust model validation is a critical step in reproducibly predicting which individuals have been exposed to significant levels of radiation.
Methods

Datasets
Murine gene expression datasets 18 were obtained from peripheral blood (PB) mononuclear cell samples of ten-week old C57B16 mice that either received total body radiation at 50 cGy, 200 cGy, or 1000 cGy or were not exposed. Post-exposure, total RNA was isolated after 6 hours and expression was determined by microarray analysis using Operon Mouse V3.0. 21 . GSE6874 and GSE10640 consist of PB samples collected 6 hours post-exposure from healthy donors and patients undergoing total body irradiation at 150-200 cGy analyzed with Operon Human V3.0.2 (GEO: GPL4782) and Operon Human V4.0 (GEO: GPL6522) microarrays. GSE10640[GPL6522] consists of 32 patients treated with alkylator-based chemotherapy without radiation. GSE1725 contains lymphoblastoid cell line samples derived from 57 subjects treated with 500 cGy. RNA was extracted 4 hours after exposure. Expression was measured using Affymetrix Human Genome U95 Version 2 Array (GEO: GPL8300). GSE701 contains lymphoblastoid cell lines from Fondation Jean Dausset-CEPH which were irradiated at 300 cGy or 1000 cGy and extracted 1-24 hours after exposure. Expression was measured using the Affymetrix Human Genome U95A Array (GEO: GPL91).
Preprocessing (Figure 1, panel i)
Rows and columns of microarray data that are less than 95% complete were removed and any remaining missing values were imputed using the nearest-neighbor algorithm. Only genes that are common across all datasets have been retained. Expression values of each probe were transformed to z-scores and the mean expression value of probes for the same gene have been assigned as the expression of each gene.
Biochemically-inspired gene selection [13] [14] [15] (Figure 1 , panel ii) A literature search has been conducted to identify genes implicated in radiation response using the search queries "radiation genes," "radiation response genes," and "radiation signatures" on PubMed.
Cited genes comprise those differentially expressed after radiation exposure, genes present in DNA repair databases and other radiation signatures, and evolutionarily conserved genes that were highly expressed in radio-resistant species. A list of 998 genes was compiled [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] , Supplementary Table X) for deriving signatures.
Minimum Redundancy Maximum Relevance (mRMR) gene ranking 11, 12 (Figure 1 , panel iii) Rank is assigned by incremental selection of genes based on the mutual information difference (MID) criterion 11, 12 . Highly ranked genes have expression information that shares mutual information with radiation exposure and shares little information with expression of other genes. The MID criterion used to select the next ranked gene is
where i is a gene selected from Ω, the total gene space, S is the set of genes selected before i, |S| is the number of genes selected before i, I(i,h) is the mutual information between expression of gene i and radiation dose (h), and I(i,j) is the mutual information between expression of gene i and expression of gene j.
Support Vector Machine (SVM) Learning SVM models are classifiers that use hyperplane boundaries to separate samples into exposure classes by maximizing the distance between the separating hyperplanes and samples of each class. The fitcecoc function of MATLAB 2017a's Statistics and Machine Learning Toolbox 36 with a SVM template was used to fit SVM models to training data. The fitcecoc function was used because it allows the fitting of multiclass models, which was required for analysis of murine samples that were irradiated at four different exposure levels. The SVM models use the Gaussian radial basis function kernel and a range of selected box-constraint and kernel-scale parameters. The box-constraint, denoted by the variable C, determines how severely misclassifications are penalized during training. The kernel-scale, denoted σ, represents the width of the Gaussian radial basis function. These parameters collectively control the tradeoff between underfitting and overfitting 37 . After feature selection, a grid search is performed to determine the optimal (C,σ) combination for values of C and σ between 1 and 100000 (inclusive) by powers of 10 such that C ≥ σ.
Feature selection (FS) (Figure 1 , panel iv) 16 Greedy feature selection was used to derive signatures. Complete sequential feature selection (CSFS) sequentially adds genes to an initially empty base set. The added gene is the highest mRMRranked gene that is not already included. This is repeated until all genes have been evaluated and the best performing subset of genes is identified. Forward sequential feature selection (FSFS) sequentially adds genes from the top 50 mRMR ranked genes to an initially empty base set. The added gene is the one whose addition improves the model by the greatest margin. Backward sequential feature selection (BSFS) sequentially removes genes from the top 30 mRMR ranked genes. The gene removed is the one whose removal causes the greatest improvement in the model. For BSFS and FSFS, we measure model improvement using misclassification or log loss during k-fold validation (see Performance metrics section below). Genes are added or removed until model performance plateaus. During feature selection, C and σ parameters need to be chosen for SVM learning (see SVM Learning section above). Thus, each signature is characterized by the feature selection algorithm used, the dataset used to derive it, and the C-σ combination used for its SVM models during feature selection. Validating signatures ( Figure 1 , panel v) Stratified k-fold validation was used to validate signatures. Samples of the validation dataset were partitioned into k sets, comprised of an approximately equal distribution of radiation levels. For validation, each set was used to test a model trained on the remaining sets, resulting in predictions for all samples in the dataset. Advantages of this approach are that variation between datasets is not pertinent and that signatures can be validated on differently labeled datasets (with samples irradiated at different levels).
Validating models (Figure 1, panel vi)
Model validation requires separate training and test datasets (the training set is often used for FS). Genes from the signature are extracted from the training and test sets and their expression values are quantile normalized by sample. An important distinction between our approach and a previous study 7 is that quantile normalization is applied immediately before validation, so expression of only the genes present in the signature being validated have been normalized. By contrast, previous approaches perform quantile normalization over entire datasets; while this reduces variability in expression values within datasets, it also suppresses the dynamic range, with potential consequential effects on the prognostic value of expression data. After normalization, an SVM model was fit to training datasets and used to generate predictions from the test dataset.
Performance metrics (Figure 1, panel vii)
Performance was determined by comparing predicted radiation doses with actual radiation exposures of each sample. Metrics included misclassification error rate, goodness-of-fit, and multiclass log loss. Misclassification is the percentage of samples that were incorrectly classified, goodness-of-fit is the average absolute value difference between predicted radiation exposure and actual radiation exposure, and multi-class log loss is
where N is the number of samples, M is the number of class labels, p ij is the predicted probability that observation i is in class j, and y ij is an indicator variable equal to 1 if sample i is in class j and 0 otherwise.
Results
We discovered radiation gene signatures using the microarray data of human and mouse peripheral blood samples and human lymphoblastoid cell lines, which were validated either according to signature ( Figure 1 , panel v) or with the respective model ( Figure 1 , panel vi). The murine data were obtained from a wider range of radiation exposure levels (0 cGy, 50 cGy, 200 cGy, 1000 cGy) than the human whole body radiation datasets, which were binary comparisons of radiation effects (0 cGy vs. 150-200 cGy, 0 cGy vs. 500 cGy, or 300 cGy vs. 700 cGy). This made possible the discovery of murine gene signatures with finer granularity for discriminating individuals exposed to different exposure levels, which is not currently feasible with the human samples. Table 1 displays the murine signatures derived using our pipeline which had the best performance metrics during k-fold validation on an independent dataset. In addition to the signature information, we report the feature selection algorithm (FS Algorithm) used to discover the signature, the internal validation performance metrics (FS Misclassification fraction and FS Log Loss function A list of the most consistently appearing genes in the best performing signatures were obtained by pooling the top 20 murine signatures (assessed by validation log loss) from GSE6874[GPL4783] and GSE10640[GPL6524], and respectively collating the top 17 and 19 most frequent genes. The union of these two sets comprises 33 genes displayed within a heat map based on the frequencies of each gene (Figure 2) . Surprisingly, the compositions of signatures derived from both datasets are not as similar as one may expect. The genes that appear more frequently in signatures derived from one dataset infrequently appear in the other even though both datasets consisted of the same types of samples irradiated at the same exposure levels.
Murine gene signatures
The shared mutual information of these expressed genes with radiation dose (Figure 3 ) indicates whether only high mutual information genes appear in the best signatures or whether some lower mutual information genes may also be selected by our feature selection algorithms. The frequency of each gene among these signatures (represented by diameter of the circle) correlates with the mutual information between expression and radiation dose (ρ = 0.8016). However, it would be an oversimplification to create signatures based solely upon mutual information, since some genes in lower performing signatures exhibit higher mutual information content. Development of accurate signatures requires more than a collection of gene features whose individual expression values share information with radiation dose, since many of these genes may reveal similar information, and redundant machine learning model features. For instance, Bax and Blnk are both common among the best murine signatures, even though Blnk shares much more mutual information with radiation dose than Bax expression. Since Blnk and Bax are involved in completely different pathways -Bax is an inducer of apoptosis 38 whereas Blnk is involved in a B-cell antigen receptor signaling pathway required for optimal B-cell development 39 , they provide different types of information to the overall model. Conversely, we also observe that genes with high information content, such as Ms4a1, may appear less frequently than genes with lower information content, such as Glipr2.
Although mRMR prioritizes genes with non-redundant, complementary contributions, subsequent wrapper steps of forward and backward sequential feature selection occur independently of the mRMR ranking. mRMR reduces the list of features considered by these algorithms, but it is possible for only high mutual information genes to be selected for the final signature. Thus, the inclusion of lower mutual information genes, such as Ube2v1 and Urod, reinforces the effectiveness of the mRMR method.
The cellular roles of these protein products (Figure 2 and Figure 3 ) demonstrate a variety of pathways and functions (Figure 4) Figure 5) . Indeed, the performance of the matrix shows that the predicted errors for a small fraction of samples deviate from the actual exposures by no more than a single adjacent exposure level. Although the predictions presented in the confusion matrix come from a single iteration of k-fold validation, the standard error associated with misclassification for this signature is extremely low (0.0013) so this confusion matrix is representative of nearly all possible iterations of k-fold validation.
Human gene signatures
The best performing signatures obtained from each human dataset, assessed by k-fold validation, are presented in Table 2 . Although four human radiation datasets were available, GSE701 contained only 10 samples, which was insufficient for derivation of a unique gene signature. While k-fold validation removes the requirement for inter-dataset normalization, it assesses the ability of signatures (genes) to predict radiation exposure without tying the signatures to corresponding models. Each signature is characterized by the feature selection algorithm and its validation statistics, which have been averaged over the 3 independent datasets that were excluded from the original data used to derive the signature.
Since traditional validation typically requires separate training and test sets that feature samples irradiated at the same exposure levels, only signatures derived from GEO: GSE6874[GPL4782] and GEO: GSE10640[GPL6522] could be analyzed. Table 3 presents the best human signatures according to this validation approach. This type of external validation is the most challenging due to the variability associated with different microarray experiments and batch effects of different platforms. This potentially explains the lower performance obtained by traditional validation (Table 3) compared with k-fold validation on the same datasets ( Table 2) . The remaining human signatures are described in Supplementary Files Y1-Y5.
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To determine which human genes are most consistently selected, the most frequently appearing genes (11 or 12 depending on number of equally prevalent genes in different signatures) were compiled from the top 20 human signatures (assessed by lowest average log loss during k-fold validation) from GSE10640[GPL6522], GSE6874[GPL4782], and GSE1725. The union of these three lists indicates the relative frequencies of each gene ( Figure 6 ). Figure 7 visualizes the mutual information of gene expression ( Figure 6 ) shared with radiation dose.
While most genes have similar representation in signatures derived from different datasets, GADD45A and DDB2, in particular, are significantly more frequent in those derived from GSE1725 and GSE10640[GPL6522]. GADD45A and DDB2 are present in signatures derived from samples irradiated at different exposures (GADD45A -500 cGy, DDB2 -150-200 cGy). This raises questions as to whether these genes have a larger influence on the accuracy of individual signatures and whether their expression is calibrated to radiation exposure levels. Removal of these gene features was performed to address their impact. Genes of interest have been removed from each of the top 20 human signatures derived from various datasets and then the signatures were revalidated excluding these features (Table 4) . The difference between the validation metrics preceding and following removal of a gene represents the weight of the gene within a signature. ΔMC, ΔLL, and ΔGoF represent the changes in misclassification, log loss, and goodness of fit, respectively.
GADD45A appears in 14 of the top 20 signatures derived from GSE1725. Of the 14 signatures, 10 were single gene signatures, as GADD45A alone was expected to sufficiently distinguish irradiated from unirradiated samples. In these cases, it was assumed that a null signature would perform as well as a predictor that randomly draws predictions from a uniform distribution of doses. Removal of GADD45A from these 14 signatures, results in an average increase in misclassification, log loss, and goodness of fit by 0.319, 0.368, and 109 cGy, respectively (see Table 4a ).
In contrast, elimination of BAX, which only appears in 2 of the top 20 signatures derived from GSE1725 and results in an average increase in misclassification, log loss, and goodness of fit by 0.018, 0.147, and 2.95 cGy respectively (Table 4e ). Comparing the effects of removing DDB2 (Table 4c ) and PRKAB1 (Table 4f) from the top 20 GSE10640[GPL6522] signatures confirms the impact of genes that frequently occur within the most accurate gene signatures.
However, the diagnostic contributions of GADD45A and DDB2 expression to the radiation levels at which samples were exposed (500 cGy and 150-200 cGy respectively) are confounding. The effects on model performance resulting from removal of GADD45A from the GSE10640[GPL6522] signatures (Table 4b ) versus the GSE1725 signatures (Table 4a) are discordant. ΔMC is higher when GADD45A is removed from GSE1725, but ΔLL is higher when GADD45A is removed from GSE10640[GPL6522]. ΔLL is large when GADD45A is removed from both datasets, which is consistent with the importance of GADD45A at both radiation doses. Indeed, GADD45A expression has been demonstrated to be rapidly induced by radiation levels as low as 2 Gy
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. Similar discordance was observed in the feature removal experiments of DDB2 (Table 4c, 4d).
As was the case with murine signatures, genes appearing in the best human signatures do not necessarily share high mutual information with radiation dose. However, the compositions of the human signatures are dominated by four genes, DDB2, GADD45A, PCNA, and PPM1D, which all share a lot of information with radiation dose (DDB2: 0.55, GADD45A: 0.39, PCNA: 0.51, PPM1D: 0.46). The functions associated with these and less frequently appearing genes are depicted in Figure 8 . The pathways and functions represented include keratinocyte differentiation ). The four common genes belong to the DNA repair and regulating JNK-p38 (MAPK14) pathways, which may imply particular significance to these functions in human response to radiation exposure. Interestingly, GADD45A and PPMD1 are antagonistic, that is, GADD45A activates while PPMD1 inhibits p38.
Discussion
Biochemically inspired genomic signatures of human and murine radiation response exhibit high accuracies in validating independent datasets (98% in k-fold validation, 92% by traditional methods). Some of the human signatures exhibit among the highest specificities reported (e.g. the signature DDB2, CD8A, TALDO1, PCNA, EIF4G2, LCN2, CDKN1A, PRKCH, ENO1, PPM1D) exhibited 92% accuracy when validated on GSE10640[GPL6522]. This dataset contains both radiation therapy patients (150-200 cGy) and controls (0 cGy) which include healthy donors and chemotherapy patients treated with alkylators 9 . Thus, the signature distinguished radiation-induced and chemotherapy-associated DNA damage.
Some of the best performing signatures consisted of one to three gene features. The first signature in Table 2 contains GADD45A and DDB2, and exhibits a misclassification error rate of 7%. These relatively short signatures have advantages over longer signatures with similar performance. It is more likely that the model can be generalized to a wider spectrum of data, when fewer features are required, and from a practical standpoint, diagnostic tests based on fewer gene expression measurements are less susceptible to experimental error.
BAX, an inducer of apoptosis, was the single gene shared among those frequently appearing in both murine and human signatures. One possible explanation for this is that the mouse datasets featured samples irradiated at four levels while human datasets contained samples irradiated at two levels. Genes selected by multi-class model algorithms may better discriminate radiation dose. Nonetheless, the radiation response pathways of mice are not necessarily similar to those of humans. In fact, Lucas et al. have shown that the murine signatures they developed are not translatable to human samples 42 . Furthermore, only two genes, including BAX, are shared by the human and murine signatures derived by Dressman et al. 42 .
None of the samples exposed to ≥200 cGy are misclassified below this radiation dose based on the multi-class murine signatures ( Figure 5 ). In the future, a similar analyses could be performed in clinical studies of human subjects exposed to different radiation levels, which might prove useful for determining treatment eligibility after exposure to high levels of myelosuppressive radiation 43 .
A comparison of the most frequently appearing genes in the optimal human ( Figure 6 ) and mouse signatures (Figure 2 ) with signatures previously derived in other studies reveals little overlap (Table 5 ). The compositional differences can be attributed to types of samples used for model training, microarray platforms used, and feature selection techniques used in deriving signatures. However, genes consistently selected in optimized signatures in at least three independent studies include BAX, DDB2, GADD45A, LY9, and TRIM22. Expression of these genes is indeed predictive of radiation dose and not a result of noise in individual datasets. An ensemble signature consisting of these genes achieves up to 92.3% accuracy in k-fold validation over 277 samples and up to 81.2% accuracy in traditional validation over 78 samples. The quality of the gene signature is largely determined by the quality and amount of training data used to fit the SVM model. Thus, this level of accuracy is not the upper bound on the performance of an SVM of the ensemble signature. Additional data at exposures with fixed levels of radiation in matched training and testing samples could improve model performance.
Ensemble models should be considered which combine genes discovered in different well-performing signatures. Although the most frequently represented human and murine genes were compiled, genes common to one dataset did not appear equally frequently in signatures from the other. This discordance may possibly result of noise in the different datasets, or perhaps to intrinsic differences between them. Compilation of frequently appearing genes in different datasets may be useful for discovery of consistently represented genes that are incorporated into high-performance signatures.
The types of data available for this study and the analytical approaches we used potentially limited the interpretation of these gene signatures. Blood samples of mouse and human datasets were all collected within 24 hours of exposure. Thus, signatures derived on these datasets may only be valid in white blood cells with a limited time window (<24 hours). Additionally, one of the datasets we used to derive signatures, GSE6874, appears to have been a particularly noisy dataset, based on the average misclassification rates on GSE10640, GSE1725, and GSE6874 of 0.03, 0.02, and 0.11, respectively. Assuming that it is possible to differentiate samples irradiated at different levels of exposure using expression data, the feature selection misclassification metric estimates the theoretical limit of how well differentially irradiated samples can be separated based on expression. The surprisingly high feature selection misclassification values obtained from GSE6874 may therefore be indicative of greater levels of noise in the data. Lastly, the greedy feature selection algorithms used to derive signatures cannot guarantee optimal results, that is, we cannot confirm that we have found the best possible signatures from each dataset for predicting radiation exposure. This potentially explains the discordance in gene composition between murine datasets (Figure 2) .
Nevertheless, the validation performance of radiation signatures is significantly improved (Table 5 ). The signatures that were externally k-fold validated achieved nearly 100% accuracy. Some of our human signature models are also externally validated in the traditional sense (i.e. using a single model). This validation method, which is representative of an actual scenario, achieves >90% accuracy, and is directly relevant to creating a routine, efficient and highly accurate expression-based radiation prognostic assay.
Data availability
All data underlying the results are available as part of the article and no additional source data are required. Sci Rep 2016). The latter study also showed for the first time the suitability of exon et al., signatures as sensitive radiation biomarkers, and highlights the importance of prior knowledge at the exon level for subsequent primer-or probe-based assays (e.g. qRT-PCR). This may be discussed.
Methods
In the data Pre-processing "Rows and columns of microarray data that are less than 95% complete were removed and any remaining missing values were imputed using the nearest-neighbor algorithm" How many rows and columns were removed, and on which basis was the 95% threshold selected. Also, what is the effect of the nearest-neighbor algorithm on the data "over-fitting". Is it possible to perform PCA on the data after removing any row/columns with less than 100% completeness and compare to the currently presented approach (95% removal and filling the remainder of the missing data)? This would allow the visualization of the effect of the proposed methodology on the segregation between the various records. proposed methodology on the segregation between the various records.
Only genes common to all datasets were retained. Does that mean common between mouse and human datasets? How were aliases identified?
The second step in the process is the selection of genes based on a non-exhaustive list of publications. Why was this necessary if the mRMR method for feature selection was applied?
I particularly like the idea of performing quantile normalization after feature selection. Is this something that has been published before? Can the authors speculate (or maybe even compare) about the performance of their method on pre-normalized datasets?
Concerning the method used for the "Validation of models", I would think this approach would be more vulnerable towards the test/training dataset. What would occur to the accuracy when doing the normalization over-all of the data? Would the accuracy change drastically? Is it possible to extend the testing to cover additional data?
Many datasets exist on human PBMCs/whole blood irradiated with a range of doses. Why were these datasets not considered for this study while lymphoblastoid cell lines were?
It would be helpful to have a comparison of model performance with that of "traditional" machine learning methods, as used in some of the indicated references.
Results
"We discovered radiation gene signatures using the microarray data of human and mouse peripheral blood samples and human lymphoblastoid cell lines, which were validated either according to signature." Were the human lymphoblastoid cell line and prepheral blood samples grouped together in one model? If so, would it be possible to visualize how the expression data of the shortlisted genes for each data type separately (using PCA for example)?
Can the authors comment on their observation that signatures derived from both murine datasets are not very similar? Apart from "noise, or intrinsic differences in the datasets", could it possibly also be a consequence of the method used, i.e. mRMR in which low mutual information genes are selected? Based on Fig. 2 and 6 it seems that genes with higher mutual information in general have higher frequencies. Which seems logical.
compositions of human signatures are dominated by genes with high mutual information (in fact, these are all well known p53-dependent genes which appear in a high number of published radiation signatures).
Discussion
I understand the advantage of small signatures in terms of practicality. However, in case of a real emergency, in which individuals have been irradiated without good knowledge about the exact time since exposure, larger gene signatures may provide the additional benefit of having different dynamics per gene. This may help to also predict not only the dose, but also the time since exposure. Furthermore, one-gene signatures may suffer from higher variability among the population compared to larger gene signatures.
I believe results from other, similar studies may be briefly situated in the introduction/discussion.
